DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES

DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES

Everest Medicines licenses exclusive rights to commercialise DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) in Greater China, South...

DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINE

Everest Medicines licenses exclusive rights to commercialise DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) in Greater China, South Korea and Southeast Asia 500,000-1 million people are estimated to be living with FSGS in the territories[1] Dimerix eligible to receive upfront and potential success-based milestone payments of up to ~AU$481[2] million, plus royalties US$10 million (~AU$14.1 million2) upfront payment Up to …

Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix for DMX-200 in Greater China, South Korea and Southeast Asia

HONG KONG, Jun 16, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK)announced that it has entered into an exclusive licensing agreement with Australia Dimerix Limited ("Dimerix"), for the development and commercialization of DMX-200 in Greater China (Chinese mainland, Hong Kong SAR, Macao SAR and Taiwan region), South Korea and certain Southeast Asian countries (Singapore, Malaysia, Thailand, Indonesia, Vietnam and Philippines). This coll…

Dimerix inks Asian licensing deal worth up to $480 million for kidney disease drug

Dimerix has signed an exclusive licensing agreement for DMX-200 with Everest Medicines The deal for the phase III kidney drug candidate covers Greater China, South Korea and key Southeast Asian markets Transaction includes a US$10 million upfront payment and up to US$330 million in potential milestone payments and sales royalties   Special Report: Dimerix has further expanded the global commercial footprint of its lead phase III kidney disease d…